Ten-year experience of carbon dioxide laser ablation as treatment for cutaneous recurrence of malignant melanoma

The British Journal of Surgery
S C GibsonA J McKay

Abstract

Cutaneous recurrence of malignant melanoma is distressing for the patient, can be difficult to palliate and is resistant to treatment by conventional methods. Experience with carbon dioxide laser ablation was reviewed to determine the initial efficacy, time to recurrence, number of treatments required and length of palliation achieved. Using a departmental database and case notes, a review was carried out of all patients undergoing laser ablation in the authors' unit between September 1992 August 2002. Forty-two patients received 105 (mean 2.5) treatments. The median time to recurrence was 5.2 (range 1.2-72.0) months. Twenty-three patients were still alive, with a median time from first laser ablation of 5.4 (range 0.5-10.0) years. Nineteen patients had died, a median of 0.8 (range 0.1-5.3) years after the first ablation. Ten of the 23 patients were disease-free for more than 1 year. No limbs were amputated because of failure to control disease. Laser ablation is a practical and useful method of palliating recurrent cutaneous malignant melanoma.

References

Apr 1, 1996·The British Journal of Surgery·S Hill, J M Thomas
Oct 1, 1996·The British Journal of Surgery·B C VrouenraetsB B Kroon
Dec 11, 1997·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·L J StrobbeB B Kroon
Jun 25, 2002·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·Claus Garbe
Jul 9, 2002·The British Journal of Dermatology·F MeierC Garbe

❮ Previous
Next ❯

Citations

Nov 15, 2006·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·P RehbergerJ Schmitt
Aug 3, 2013·Current Oncology Reports·Malcolm Hart Squires, Keith A Delman
Aug 13, 2011·Journal of Agricultural and Food Chemistry·Sarah A Teichert, Casimir C Akoh
Jan 15, 2005·Current Opinion in Lipidology·Toru SeoRichard J Deckelbaum
May 11, 2012·Current Opinion in Oncology·Catherine MénardYves Libert
May 7, 2008·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Nanda Kandamany, Peter Mahaffey
Oct 19, 2011·Lasers in Surgery and Medicine·Mehmet A KosogluChristopher G Rylander
Feb 22, 2012·International Journal of Dermatology·Kurtis B ReedJerry D Brewer
Nov 20, 2013·Journal of Surgical Oncology·Hannah E John, Peter J Mahaffey
Dec 20, 2011·Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology·Lennard K W Chan, Awf A Quaba
Jul 20, 2013·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Roger OlofssonPer Lindnér
Mar 23, 2005·Photomedicine and Laser Surgery
Feb 3, 2005·Photomedicine and Laser Surgery
Apr 9, 2008·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·H J Hoekstra
Nov 7, 2019·Expert Review of Clinical Pharmacology·Rebecca L Read, John F Thompson
Dec 19, 2014·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Jorien A van JarwaardeJos A van der Hage
Feb 9, 2019·Journal of Surgical Oncology·Tavis ReadB Mark Smithers
Jun 27, 2019·Melanoma Management·Otis M VrielinkJan Ln Roodenburg
Jul 4, 2008·Cancer Control : Journal of the Moffitt Cancer Center·James M McLoughlinLawrence B Berk
Jul 4, 2008·Cancer Control : Journal of the Moffitt Cancer Center·Mark I GimbelJonathan S Zager

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.